换一批Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
第一作者：
Irene,Ganan-Gomez
作者：
Irene,Ganan-Gomez [1]
;
Hui,Yang [2]
;
Feiyang,Ma [3]
;
Guillermo,Montalban-Bravo [4]
;
Natthakan,Thongon [5]
;
Valentina,Marchica [6]
;
Guillaume,Richard-Carpentier [7]
;
Kelly,Chien [8]
;
Ganiraju,Manyam [9]
;
Feng,Wang [10]
;
Ana,Alfonso ;
Shuaitong,Chen ;
Caleb,Class ;
Rashmi,Kanagal-Shamanna ;
Justin P.,Ingram ;
Yamini,Ogoti ;
Ashley,Rose ;
Sanam,Loghavi ;
Pamela,Lockyer ;
Benedetta,Cambo ;
Muharrem,Muftuoglu ;
Sarah,Schneider ;
Vera,Adema ;
Michael,McLellan ;
John,Garza ;
Matteo,Marchesini ;
Nicola,Giuliani ;
Matteo,Pellegrini ;
Jing,Wang ;
Jason,Walker ;
Ziyi,Li ;
Koichi,Takahashi ;
Joel D.,Leverson ;
Carlos,Bueso-Ramos ;
Michael,Andreeff ;
Karen,Clise-Dwyer ;
Guillermo,Garcia-Manero ;
Simona,Colla
作者单位：
Department of Leukemia,The University of Texas MD Anderson Cancer Center
[1]
Molecular Biology Institute,University of California, Los Angeles
[2]
Department of Medicine and Surgery,University of Parma
[3]
Department of Bioinformatics and Computational Biology,The University of Texas MD Anderson Cancer
[4]
Department of Genomic Medicine,The University of Texas MD Anderson Cancer Center
[5]
Department of Biostatistics,The University of Texas MD Anderson Cancer Center
[6]
Department of Hematopathology,The University of Texas MD Anderson Cancer Center
[7]
AbbVie Oncology Discovery
[8]
Department of Stem Cell Transplantation and Cellular Therapy,The University of Texas MD Anderson
[9]
McDonnell Genome Institute,Washington University in St. Louis
[10]
发布时间
2022-09-30
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
